Robert P Schleimer Selected Research

Rhinosinusitis

11/2022	Use of intraoperative frontal sinus mometasone-eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps.
11/2022	Retinoic acid promotes fibrinolysis and may regulate polyp formation.
1/2022	Studies on activation and regulation of the coagulation cascade in chronic rhinosinusitis with nasal polyps.
1/2022	Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial.
1/2022	Anti-phospholipid antibodies are elevated and functionally active in chronic rhinosinusitis with nasal polyps.
1/2022	Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa.
10/2021	Epithelial-Cell-Derived Extracellular Vesicles in Pathophysiology of Epithelial Injury and Repair in Chronic Rhinosinusitis: Connecting Immunology in Research Lab to Biomarkers in Clinics.
9/2021	Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis.
1/2021	Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps.
1/2021	Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert P Schleimer Research Topics

Disease

59	Rhinosinusitis 11/2022 - 12/2004
56	Nasal Polyps (Nasal Polyp) 11/2022 - 06/2008
37	Inflammation (Inflammations) 01/2022 - 01/2002
34	Asthma (Bronchial Asthma) 01/2022 - 01/2002
12	Polyps 11/2022 - 03/2006
8	Infections 01/2021 - 01/2005
6	Virus Diseases (Viral Diseases) 01/2021 - 07/2007
5	Hypersensitivity (Allergy) 01/2022 - 05/2009
4	Eosinophilia 11/2017 - 01/2009
4	type 2C Congenital disorder of glycosylation 01/2015 - 03/2008
3	Edema (Dropsy) 01/2020 - 01/2013
3	Communicable Diseases (Infectious Diseases) 01/2018 - 01/2005
3	Airway Remodeling 04/2015 - 06/2012
2	Bronchiectasis 01/2022 - 12/2019
2	Fibrosis (Cirrhosis) 01/2021 - 04/2014
2	Pneumonia (Pneumonitis) 01/2021 - 07/2017
2	Anosmia 11/2019 - 07/2016
2	Food Hypersensitivity (Food Allergy) 01/2019 - 01/2009
2	Allergic Rhinitis 01/2017 - 01/2016
2	Gastroesophageal Reflux (GERD) 01/2016 - 05/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2015 - 01/2005
2	Hyperplasia 04/2014 - 06/2012
2	Respiratory Hypersensitivity 04/2014 - 06/2012
2	Anaphylaxis (Anaphylactic Shock) 01/2013 - 01/2009
2	Necrosis 10/2010 - 03/2008
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2022
1	Thrombosis (Thrombus) 01/2022

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 01/2022 - 01/2004
15	Messenger RNA (mRNA)IBA 01/2022 - 11/2004
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2004
13	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 07/2011
10	AntibodiesIBA 01/2022 - 12/2011
9	FibrinIBA 11/2022 - 01/2013
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2012
9	Immunoglobulin E (IgE)IBA 01/2021 - 09/2008
9	AllergensIBA 01/2019 - 09/2008
8	ChemokinesIBA 01/2013 - 01/2004
7	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 02/2003
7	GlucocorticoidsIBA 01/2017 - 01/2002
6	Interleukin-13IBA 11/2022 - 08/2008
6	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2008
6	LigandsIBA 01/2017 - 07/2010
5	Immunoglobulin G (IgG)IBA 01/2022 - 09/2008
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 05/2009
5	Complement System Proteins (Complement)IBA 01/2021 - 01/2005
5	Thymic Stromal LymphopoietinIBA 01/2020 - 07/2007
5	EnzymesIBA 11/2017 - 01/2004
4	Plasminogen Activators (Plasminogen Activator)IBA 11/2022 - 06/2012
4	Interleukin-5 (Interleukin 5)IBA 11/2022 - 01/2017
4	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 01/2013
4	AutoantibodiesIBA 01/2022 - 12/2011
4	Cyclooxygenase 1IBA 01/2021 - 07/2017
4	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2010 - 12/2004
3	Interleukin-4 (Interleukin 4)IBA 01/2022 - 03/2008
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 02/2010
3	Pattern Recognition ReceptorsIBA 01/2021 - 01/2006
3	Blood Proteins (Serum Proteins)IBA 01/2020 - 01/2013
3	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 06/2008
3	ImmunosorbentsIBA 11/2017 - 10/2010
3	LipopolysaccharidesIBA 01/2017 - 07/2010
3	Fluticasone (Cutivate)FDA LinkGeneric 01/2014 - 01/2002
3	AntigensIBA 04/2013 - 04/2005
2	Mometasone Furoate (Nasonex)FDA LinkGeneric 11/2022 - 01/2002
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2022 - 01/2022
2	OvalbuminIBA 01/2022 - 01/2016
2	Eosinophil Cationic ProteinIBA 01/2022 - 11/2017
2	ORALIT (ORS)IBA 01/2022 - 01/2016
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2020
2	Tryptases (Tryptase)IBA 01/2020 - 08/2012
2	Pharmaceutical PreparationsIBA 01/2019 - 02/2010
2	Chemokine CCL26IBA 01/2017 - 11/2004
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 04/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017 - 02/2013
2	Sialic Acid Binding Immunoglobulin-like LectinsIBA 02/2016 - 03/2015
2	Enterotoxins (Enterotoxin)IBA 01/2016 - 01/2009
2	S100 Proteins (S 100 Protein)IBA 11/2015 - 03/2010
2	Factor XIII (Coagulation Factor XIII)IBA 09/2015 - 09/2013
2	Plasminogen Activator Inhibitor 1IBA 01/2015 - 06/2012
2	Substance PIBA 01/2014 - 10/2010
2	Interleukin-1 (Interleukin 1)IBA 07/2012 - 07/2011
2	Immunoglobulin A (IgA)IBA 12/2011 - 06/2008
2	B-Cell Activating FactorIBA 12/2011 - 06/2008
2	InterleukinsIBA 10/2010 - 07/2010
2	NeuropeptidesIBA 10/2010 - 03/2008
2	LuciferasesIBA 07/2010 - 11/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2010 - 07/2007
2	Interleukin-10 (Interleukin 10)IBA 07/2010 - 01/2002
2	Chemokine CCL5IBA 01/2010 - 07/2007
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2008 - 07/2007
2	Collectins (Collectin)IBA 07/2007 - 01/2005
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2006 - 01/2006
1	fibrin fragment D (D-dimer)IBA 11/2022
1	RetinoidsIBA 11/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Volatile Fatty AcidsIBA 01/2022
1	Uridine Triphosphate (UTP)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2002
1	Stents 11/2022